SLC9A3 and inflammatory bowel disease: Of note, a number of patients with these mutations develop inflammatory bowel disease (IBD), implying that NHE3 dysfunction directly or indirectly predisposes patients to IBD (Anderson et al., 2011; Jostins et al., 2012).